OTC

Hapbee Expands Distribution to Seniors, Caregivers, and Communities Through Gray Matters Alliance

by

Agreement Facilitates Coverage For Hapbee Devices Under The Medicaid Waiver For Assistive Technology VANCOUVER, BC, May 18, 2023 /PRNewswire/ – Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company”) the wearable, wellness technology company and creator of the Hapbee Smart Sleep Pad, has announced an agreement with Gray Matters Alliance (GMA) … Read more

OncoSec Announces Closing of $1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

by

EWING, N.J. and SAN DIEGO, May 18, 2023 /PRNewswire/ — OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patient’s immune system to target cancer cells and eradicate disease, today announced the closing of its previously announced registered direct offering of 1,408,384 shares of its … Read more

Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit

by

NEW YORK, May 18, 2023 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that Chief Scientific Officer Dr. Miriam Kidron will deliver an in-person presentation at the Novel Therapies for Type 2 Diabetes & Obesity Summit in Boston, MA, on May 31, 2023. The presentation will include an overview of Oramed’s oral … Read more

Kapruvia® (difelikefalin) recommended by England’s NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus

by

Recommendation will enable eligible patients in England, Wales and Northern Ireland to access the first licensed treatment for moderate-to-severe chronic kidney disease (CKD)-associated pruritus in adult patients on haemodialysis ST. GALLEN, Switzerland and STAMFORD, Conn., May 18, 2023 /PRNewswire/ — Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that … Read more

Curaleaf Reports First Quarter 2023 Results

by

First quarter 2023 revenue of $336.5 million, representing an increase of 14% year-over-year, and adjusted EBITDA(1) of $73.2 million Operating cash flow from continuing operations of $30.6 million and cash on balance sheet of $115.8 million NEW YORK, May 17, 2023 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer … Read more

Evofem Biosciences Announces 1-for-125 Reverse Stock Split

by

— CUSIP number for Evofem will change to 30048L302 on May 18, 2023 — — Ticker symbol will change to “EVFMD” for 20 business days, then revert to “EVFM” — SAN DIEGO, May 17, 2023 /PRNewswire/ — Evofem Biosciences, Inc., (OTCQB: EVFM) (the “Company”) today announced a 1-for-125 reverse stock split of the Company’s common stock, … Read more

EXACT SCIENCES AWARDS GRANTS TO 18 ORGANIZATIONS FOCUSED ON INCREASING COLORECTAL CANCER SCREENINGS

by

MADISON, Wis., May 17, 2023 /PRNewswire/ — Exact Sciences, a leading provider of cancer screening and diagnostic tests, announced today that it awarded $1.1 million to 18 organizations through its Funding Opportunities for CRC Screening Uptake Strategies (FOCUS) Program. Grant recipients are committed to improving uptake of colorectal cancer (CRC) screening and supporting affordable pathways to follow-up … Read more

RaySearch Laboratories: Interim report January 1

by

STOCKHOLM, May 17, 2023 /PRNewswire/ —  FIRST QUARTER (JANUARY – MARCH 2023) Order intake SEK 206.6 M (272.5) Net sales SEK 230.2 M (208.1) Operating profit SEK 23.7 M (29.6) Profit after tax SEK 17.6 M (19.3) Earnings per share before/after dilution SEK 0.51 (0.56) Cash flow SEK 84.5 M (35.3) Order backlog SEK 1,903.3 … Read more

Roche showcases commitment to advancing innovative diagnostic solutions at WorldLab-EuroMedLab

by

Roche will unveil the next generation of its serum work area, several molecular systems and the cobas® connection module. The company will  introduce navify® digital solutions that help laboratories address their needs for digital infrastructure, operational excellence and medical insights. Attendees can experience an integrated lab that goes beyond simply connecting individual technologies to demonstrate … Read more

Roche showcases commitment to advancing innovative diagnostic solutions at WorldLab-EuroMedLab

by

Roche will unveil the next generation of its serum work area, several molecular systems and the cobas® connection module. The company will  introduce navify® digital solutions that help laboratories address their needs for digital infrastructure, operational excellence and medical insights. Attendees can experience an integrated lab that goes beyond simply connecting individual technologies to demonstrate … Read more